The IBT Connection Study

Description:

To evaluate the efficacy of IBP-9414 (study drug) vs. placebo on the prevention of necrotizing enterocolitis (NEC) and on sustained feeding tolerance in very low birth weight premature infants, as well as the safety of IBP-9414 (study drug) vs. placebo.

I'M INTERESTED

This research study is led by Rachana Singh, MD, MS.

Contact: 413-794-2207

Participation details:

Start Date: July 01, 2019

Condition/Disease: Pregnancy, Pediatrics

Location: Baystate Medical Center, 759 Chestnut St, Springfield, MA

Eligibility: Gestational age at birth of 23 weeks +0 days -32 weeks +0 days. Birth weight 500-1500g.

Time Commitment: The study will end when the patient is discharged from the hospital and has completed GA week 40 follow up visit/call.